• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于体内剂量测定的腹膜腔模型。

A model of the peritoneal cavity for use in internal dosimetry.

作者信息

Watson E E, Stabin M G, Davis J L, Eckerman K F

机构信息

Oak Ridge Associated Universities, Tennessee.

出版信息

J Nucl Med. 1989 Dec;30(12):2002-11.

PMID:2585102
Abstract

Several therapeutic and diagnostic techniques involve injection of radioactive material into the peritoneal cavity. Estimation of the radiation dose to the surface of the peritoneum or to surrounding organs is hampered by the lack of a suitable source region in the phantom commonly used for such calculations. We have modified the Fisher-Snyder phantom to include a region representing the peritoneal cavity which may be employed to estimate such radiation doses. A geometric model is described which is coordinated with the existing organ regions in the phantom. Specific absorbed fractions (derived by Monte Carlo techniques) for photon emissions originating within the cavity are listed. Photon S-values for several radionuclides which have been administered intraperitoneally are shown. Dose conversion factors for electrons irradiating the peritoneal cavity wall, from either a thin plane or volume source of activity within the cavity, are also given for several nuclides.

摘要

几种治疗和诊断技术涉及将放射性物质注入腹腔。由于在通常用于此类计算的体模中缺乏合适的源区域,因此难以估计腹膜表面或周围器官的辐射剂量。我们对费舍尔 - 斯奈德体模进行了修改,使其包含一个代表腹腔的区域,可用于估计此类辐射剂量。描述了一种与体模中现有器官区域相协调的几何模型。列出了源自腔内的光子发射的特定吸收分数(通过蒙特卡罗技术得出)。展示了几种经腹腔给药的放射性核素的光子S值。还给出了几种核素从腔内薄平面或体积活度源照射腹膜腔壁的电子剂量转换因子。

相似文献

1
A model of the peritoneal cavity for use in internal dosimetry.一种用于体内剂量测定的腹膜腔模型。
J Nucl Med. 1989 Dec;30(12):2002-11.
2
A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.一种用于大鼠器官剂量测定的程式化计算模型,以支持用(90)钇、(111)铟或(177)镥进行肽受体放射性核素治疗的临床前评估。
J Nucl Med. 2004 Jul;45(7):1260-9.
3
Absorbed fractions for electrons and beta particles in spheres of various sizes.不同尺寸球体中电子和β粒子的吸收分数。
J Nucl Med. 1994 Jan;35(1):152-6.
4
Estimates of radiation dose to the embryo from nuclear medicine procedures.
J Nucl Med. 1976 Sep;17(9):836-9.
5
Paired-organ and other selected absorbed fraction for the Korean Reference Adult Male model.韩国参考成年男性模型的成对器官及其他选定吸收分数。
Radiat Prot Dosimetry. 2006;118(4):395-401. doi: 10.1093/rpd/nci359. Epub 2005 Dec 15.
6
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.(125/131)I-、(186)Re-、(88/90)Y-或(177)Lu标记的抗癌胚抗原单克隆抗体MN-14在结直肠癌源性小腹膜转移小鼠中的生物分布及治疗效果
J Nucl Med. 2004 Jul;45(7):1224-32.
7
A dosimetry model for the small intestine incorporating intestinal wall activity and cross-doses.一种纳入肠壁活性和交叉剂量的小肠剂量测定模型。
J Nucl Med. 2002 Dec;43(12):1657-64.
8
Effect of respiratory motion on internal radiation dosimetry.呼吸运动对体内辐射剂量测定的影响。
Med Phys. 2014 Nov;41(11):112506. doi: 10.1118/1.4898118.
9
Patient-specific scaling of reference S-values for cross-organ radionuclide S-values: what is appropriate?用于跨器官放射性核素S值的患者特异性参考S值缩放:什么是合适的?
Radiat Prot Dosimetry. 2007;127(1-4):192-6. doi: 10.1093/rpd/ncm270. Epub 2007 Jun 14.
10
Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicity.
J Nucl Med. 2002 Aug;43(8):1110-4.

引用本文的文献

1
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials.EANM 指导文件:用于首次人体研究和早期临床试验的剂量学。
Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1268-1286. doi: 10.1007/s00259-024-06640-x. Epub 2024 Feb 17.
2
Biodistribution and Radiation Dosimetry of Intraperitoneally Administered I-Omburtamab in Patients with Desmoplastic Small Round Cell Tumors.腹腔内给予 I-Omburtamab 治疗硬纤维瘤型小圆细胞肿瘤患者的生物分布和辐射剂量学。
J Nucl Med. 2022 Jul;63(7):1094-1100. doi: 10.2967/jnumed.121.262793. Epub 2021 Dec 2.
3
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.
B7H3 导向的奥姆巴鲁单抗放射性碘免疫治疗用于硬纤维瘤和其他腹膜肿瘤:I 期研究结果。
J Clin Oncol. 2020 Dec 20;38(36):4283-4291. doi: 10.1200/JCO.20.01974. Epub 2020 Oct 29.
4
Radiopharmaceutical therapy in cancer: clinical advances and challenges.放射性药物治疗癌症:临床进展与挑战。
Nat Rev Drug Discov. 2020 Sep;19(9):589-608. doi: 10.1038/s41573-020-0073-9. Epub 2020 Jul 29.
5
Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin.使用生物素化单克隆抗体和放射性链霉亲和素对卵巢癌患者进行两步肿瘤靶向治疗。
Eur J Nucl Med. 1992;19(5):322-9. doi: 10.1007/BF00177053.